ATE305967T1 - Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung - Google Patents

Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung

Info

Publication number
ATE305967T1
ATE305967T1 AT99962807T AT99962807T ATE305967T1 AT E305967 T1 ATE305967 T1 AT E305967T1 AT 99962807 T AT99962807 T AT 99962807T AT 99962807 T AT99962807 T AT 99962807T AT E305967 T1 ATE305967 T1 AT E305967T1
Authority
AT
Austria
Prior art keywords
tissue constructs
biotechnically
production
cultured
matrix components
Prior art date
Application number
AT99962807T
Other languages
English (en)
Inventor
Michael P Murphy
Vincent Ronfard
Original Assignee
Organogenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organogenesis Inc filed Critical Organogenesis Inc
Application granted granted Critical
Publication of ATE305967T1 publication Critical patent/ATE305967T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/09Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
AT99962807T 1998-11-19 1999-11-19 Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung ATE305967T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10924798P 1998-11-19 1998-11-19
US33963299A 1999-06-24 1999-06-24
PCT/US1999/027505 WO2000029553A1 (en) 1998-11-19 1999-11-19 Bioengineered tissue constructs and methods for producing and using them

Publications (1)

Publication Number Publication Date
ATE305967T1 true ATE305967T1 (de) 2005-10-15

Family

ID=26806787

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99962807T ATE305967T1 (de) 1998-11-19 1999-11-19 Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung

Country Status (15)

Country Link
US (2) US7824913B2 (de)
EP (3) EP2295540A1 (de)
JP (2) JP2002530069A (de)
CN (2) CN102051343A (de)
AT (1) ATE305967T1 (de)
AU (3) AU769637B2 (de)
BR (1) BR9915476A (de)
CA (1) CA2351396C (de)
DE (1) DE69927600T2 (de)
DK (1) DK1131410T3 (de)
ES (2) ES2402739T3 (de)
HK (1) HK1040740A1 (de)
IL (1) IL143243A0 (de)
PT (1) PT1612265E (de)
WO (1) WO2000029553A1 (de)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295540A1 (de) * 1998-11-19 2011-03-16 Organogenesis, Inc. Biotechnisch konstruiertes Gewebe und Verfahren zu dessen Produktion und Benutzung
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20020042128A1 (en) * 2000-09-01 2002-04-11 Bowlin Gary L. Electroprocessed fibrin-based matrices and tissues
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US20020081732A1 (en) * 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US20040018226A1 (en) * 1999-02-25 2004-01-29 Wnek Gary E. Electroprocessing of materials useful in drug delivery and cell encapsulation
JP4017977B2 (ja) * 2000-08-08 2007-12-05 アデランス リサーチ インスティテュート インコーポレイテッド 組織工学で処置した毛髪用の台
ES2288995T3 (es) 2000-09-18 2008-02-01 Organogenesis Inc. Metodo para el tratamiento de un paciente que utiliza una construccion de tejido conjuntivo cultivado.
EP1832300A3 (de) * 2000-09-18 2008-02-27 Organogenesis Inc. Verfahren zur Behandlung eines Patienten unter Verwendung eines kultivierten Bindegewebekonstrukts
JP4366075B2 (ja) * 2000-09-21 2009-11-18 株式会社資生堂 角質細胞の成熟度の評価方法
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
JP4822635B2 (ja) * 2001-09-05 2011-11-24 株式会社 資生堂 人工毛球部及びその製造方法、並びに、人工毛球部を用いた薬剤の評価方法
EP1444994B1 (de) * 2001-10-15 2014-07-30 Japan Science and Technology Agency Verfahren zur bildung von normalem regeneriertem gewebe; das normale regenerierte gewebe und verfahren zur kalibrierung der sensitivität und dergleichen
FR2833610B1 (fr) * 2001-12-14 2007-01-26 Natural Implant Construits cellulaires cultives in vitro, preparation et utilisations
DE10162814B4 (de) * 2001-12-19 2005-06-23 Henkel Kgaa Rekonstruiertes Haarfollikelmodell
US20050089512A1 (en) * 2001-12-19 2005-04-28 Kordula Schlotmann Skin/hair equivalent with reconstructed papillae
DE10220472A1 (de) * 2002-05-07 2003-11-27 Hans-Guenther Machens Bioartifizielle Haut
JP2005532853A (ja) * 2002-07-16 2005-11-04 バイオジェンティス、インコーポレーテッド 人工組織の作製方法
GB0304918D0 (en) * 2003-03-05 2003-04-09 Celltran Ltd Cell culture
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
CA2530490A1 (en) 2003-06-25 2005-01-13 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
US8043614B2 (en) * 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
KR101156868B1 (ko) * 2003-10-06 2012-06-21 가부시키가이샤 시세이도 모포 재생용 조성물
JP2005218445A (ja) * 2004-01-09 2005-08-18 Technology Seed Incubation Co Ltd 培養皮膚細胞とこれを原料として用いた移植用材及び遺伝子解析用材並びに培養皮膚細胞の製造方法
WO2006048783A2 (en) * 2004-03-09 2006-05-11 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
AU2005300263A1 (en) * 2004-03-09 2006-05-11 Jan-Eric W. Ahlfors Autogenic living scaffolds and living tissue matrices: methods and uses thereof
US7597885B2 (en) 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
US7597687B2 (en) 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
WO2006053291A2 (en) 2004-11-09 2006-05-18 Proxy Biomedical Limited Tissue scaffold
GB2441098B (en) * 2005-05-16 2010-05-26 Purdue Research Foundation Engineered extracellular matrices
JP5153638B2 (ja) * 2005-10-17 2013-02-27 アデランス リサーチ インスティテュート インコーポレイテッド 毛包前駆細胞を皮膚に送達する方法
EP1948259B1 (de) * 2005-10-26 2017-03-22 Genesis Technologies Limited Durch inkubation von azellulären blutprodukten hergestellte azelluläre bioresorbierbare geweberegenerationsmatrizen
WO2007062386A2 (en) * 2005-11-22 2007-05-31 Aderans Research Institute, Inc. Hair follicle graft from tissue engineered skin
CN101431962A (zh) * 2006-02-07 2009-05-13 器官发生有限公司 生物工程化组织构建物及其心脏用途
AU2007213706B2 (en) * 2006-02-09 2010-11-25 Aderans Research Institute, Inc. Apparatus and methods for delivering fluid and material to a subject
US9109204B2 (en) * 2006-02-28 2015-08-18 The Trustees Of Columbia University In The City Of New York Methods for compact aggregation of dermal cells
EP1998787A4 (de) * 2006-03-03 2010-04-21 Organogenesis Inc Wiederherstellung und reparatur von oralem gewebe
GB0605450D0 (en) * 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
CA2652138C (en) * 2006-05-16 2016-01-19 Purdue Research Foundation Three dimensional purified collagen matrices
US20070269476A1 (en) * 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
FR2903702B1 (fr) 2006-07-13 2012-10-19 Oreal Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
WO2008036393A1 (en) 2006-09-21 2008-03-27 Purdue Research Foundation Collagen preparation and method of isolation
US8658851B2 (en) * 2006-10-20 2014-02-25 Keracure, Inc. Devices with cells cultured on flexible supports
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
EP2079490B1 (de) * 2006-10-23 2012-08-29 Cook Biotech Incorporated Aufbereitete ecm-materialien mit erweiterten komponentenprofilen
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US20100183572A1 (en) 2007-02-28 2010-07-22 Takeshi Nakajima Cell capable of expressing lacritin at high level
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
WO2009043052A1 (en) * 2007-09-27 2009-04-02 Columbia University Methods and systems for forming biocompatible materials
JP5795166B2 (ja) * 2007-11-28 2015-10-14 オルガノジェネシス インク. 生命工学による組織コンストラクト並びに生産及び使用のための方法
CA2708615C (en) * 2007-12-10 2019-12-31 Purdue Research Foundation Collagen-based matrices with stem cells
WO2009086535A2 (en) * 2007-12-27 2009-07-09 The Trustees Of Columbia University In The City Of New York Systems and methods for forming patterned extracellular matrix materials
US8524494B2 (en) 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
SG10201500237TA (en) * 2008-01-30 2015-04-29 Histogen Inc Extracellular matrix compositions
WO2010056378A2 (en) * 2008-11-14 2010-05-20 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
US20100166822A1 (en) * 2008-12-31 2010-07-01 Howmedica Osteonics Corp. Adhesive cartilage implant
CN102459564B (zh) 2009-06-04 2018-10-02 通用医疗公司 生物人工肺
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US20110046639A1 (en) * 2009-08-24 2011-02-24 Konstantinos Giotis Method of direct hair implantation
CA2781309A1 (en) * 2009-12-04 2011-06-09 Euclid Systems Corporation Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema
EP2524034A1 (de) * 2010-01-14 2012-11-21 Organogenesis, Inc. Biotechnologisch hergestellte gewebekonstrukte sowie verfahren zu ihrer herstellung und verwendung
EP2561087A4 (de) * 2010-04-20 2013-10-16 Int Stem Cell Corp Physiologische verfahren zur isolation hochreiner zellpopulationen
EP2582791B8 (de) * 2010-06-18 2018-05-23 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Neogenese von haarfollikeln
FR2976001B1 (fr) 2011-05-30 2014-10-31 Oreal Modele de cuir chevelu reconstruit et procede de screening de molecules actives
GB201112922D0 (en) * 2011-07-27 2011-09-14 Univ Durham Micro-organ
HK1200483A1 (en) * 2011-09-12 2015-08-07 奥加诺沃公司 Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same
AU2012335070A1 (en) * 2011-11-11 2014-05-29 Bio-Ess Laboratories, Llc Kit comprising serum replacement and labile factors
ES2812281T3 (es) 2012-01-13 2021-03-16 Lifecell Corp Métodos para fabricar prótesis mamarias
HK1205707A1 (en) * 2012-03-07 2015-12-24 Fibrocell Technologies, Inc. Topical dermal formulations and methods of personalized treatment of skin
USD690004S1 (en) 2012-03-16 2013-09-17 Aderans Research Institute, Inc. Holder for a device for delivering cellular material and physiologic fluids
EP2841010B1 (de) 2012-04-24 2023-08-23 Harvard Apparatus Regenerative Technology, Inc. Träger für künstliche gewebegerüste
CA2876658C (en) 2012-06-21 2020-05-05 Lifecell Corporation Implantable prosthesis having acellular tissue attachments
US9956072B2 (en) 2012-10-04 2018-05-01 Lifecell Corporation Surgical template and delivery device
DE102012223061A1 (de) 2012-12-13 2014-06-18 Henkel Ag & Co. Kgaa Altershautmodell
EP2943231A4 (de) 2013-01-09 2016-12-07 Harvard Apparatus Regenerative Tech Inc Synthetische gerüste
SG11201506312TA (en) 2013-02-12 2015-09-29 Replicel Life Sciences Inc Compositions and methods for treating and repairing tendons
EP2991692B1 (de) 2013-05-03 2019-08-21 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Hautersatzstoffe und verfahren zur neubildung von haarfollikeln
CN103497892B (zh) * 2013-09-03 2015-12-02 中山大学 一种细胞培养基材及其制备方法和应用
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
WO2015123477A1 (en) 2014-02-12 2015-08-20 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
CN117694335A (zh) 2014-03-14 2024-03-15 通用医疗公司 肺生物反应器
JP6218238B2 (ja) * 2014-07-10 2017-10-25 国立大学法人大阪大学 人工皮膚及びその製造方法
EP3185922B1 (de) 2014-08-27 2025-04-02 Purdue Research Foundation Abgabesysteme für therapeutikum auf kollagenbasis
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
HK1253775A1 (zh) 2015-05-15 2019-07-05 Lifecell Corporation 用於整形外科的组织模型
HK1253060A1 (zh) * 2015-06-25 2019-06-06 奥克兰服务有限公司 组织培养设备和方法
WO2017024090A1 (en) * 2015-08-06 2017-02-09 The Johns Hopkins University Tissue-derived scaffolds for corneal reconstruction
EP3337427A1 (de) 2015-08-21 2018-06-27 Lifecell Corporation Brustbehandlungsvorrichtung
DE102015119880B4 (de) * 2015-11-17 2018-05-24 Technische Universität Berlin Verfahren zur Herstellung von Haarfollikeln und de novo Papillen sowie deren Verwendung für in vitro Tests und in vivo Implantate
US10624992B2 (en) 2016-05-16 2020-04-21 The General Hospital Corporation Human airway stem cells in lung epithelial engineering
JP6840774B2 (ja) 2016-05-16 2021-03-10 ザ ジェネラル ホスピタル コーポレイション 肺上皮エンジニアリングにおけるヒト気道幹細胞
RU2749991C2 (ru) 2016-08-31 2021-06-21 Лайфселл Корпорейшн Устройство для коррекции молочной железы
MX380950B (es) * 2016-09-23 2025-03-12 Univ Mexico Nac Autonoma Metodo para preparar un suplemento a partir de cultivos de celulas mesenquimales de gelatina de wharton y usos del mismo.
CN106544281B (zh) * 2016-12-07 2019-07-02 哈尔滨工业大学 一种基于蛋白质和多糖构筑生物体保护层的制备方法
CA3052266A1 (en) 2017-01-31 2018-08-09 Geniphys, Llc Methods and compositions for matrix preparation
US11739291B2 (en) 2017-04-25 2023-08-29 Purdue Research Foundation 3-dimensional (3D) tissue-engineered muscle for tissue restoration
CN109663148A (zh) * 2018-12-17 2019-04-23 太阳雨林(厦门)生物医药有限公司 一种细胞外基质高分子材料生物复合血管
US11298220B2 (en) 2019-05-03 2022-04-12 Lifecell Corporation Breast treatment device
WO2020257281A1 (en) 2019-06-18 2020-12-24 United Therapeutics Corporation Mitochondrial treatment of organs for transplantation
CN111100838B (zh) * 2019-12-27 2023-05-09 广东博溪生物科技有限公司 低温保存运输培养基
EP4096635A4 (de) 2020-01-27 2024-02-21 GeniPhys, Inc. Biologischer füllstoff zur wiederherstellung und regeneration von gewebe
US20230357684A1 (en) * 2020-09-18 2023-11-09 University Of Virginia Patent Foundation 3d-printed modular microchip with an integrated impeller pump to model inter-organ communication
CA3263788A1 (en) * 2022-08-05 2024-02-08 The Texas A&M University System MODIFIED SKIN COMPONENTS MANUFACTURED AND ASSOCIATED PROCESSES
CN119979445B (zh) * 2025-04-10 2025-09-09 四川大学 一种培养基、口腔黏膜上皮细胞模型,及其制备方法和用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
DE3317550C2 (de) 1983-05-13 1985-08-22 Stephan Priv.Doz.Dr.rer.nat.Dr.med.habil. 8000 München Nees Verfahren zum Züchten einer lückenlosen Zellschicht und Vorrichtung zur Durchführung dieses Verfahrens
US5484432A (en) * 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US5026649A (en) 1986-03-20 1991-06-25 Costar Corporation Apparatus for growing tissue cultures in vitro
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5510254A (en) 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
JPS6410983A (en) * 1987-02-19 1989-01-13 Takeda Chemical Industries Ltd Artificial tissue and production thereof
EP0282746A1 (de) * 1987-02-19 1988-09-21 Takeda Chemical Industries, Ltd. Methode zur Herstellung von künstlichem Gewebe
FR2612939B1 (fr) * 1987-03-26 1989-06-23 Cird Equivalent de peau
US4835102A (en) 1987-03-31 1989-05-30 Eugene Bell Tissue equivalent test systems
JPH051280Y2 (de) 1987-10-12 1993-01-13
IL94611A (en) 1989-06-05 1994-12-29 Organogenesis Inc Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
IL95429A (en) * 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
US5800537A (en) 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5374515A (en) 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5366893A (en) 1993-01-13 1994-11-22 Becton, Dickinson And Company Culture vessel
JPH07178A (ja) * 1993-06-11 1995-01-06 New Japan Chem Co Ltd 細胞培養用担体
US5891617A (en) 1993-09-15 1999-04-06 Organogenesis Inc. Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5741701A (en) * 1994-04-25 1998-04-21 Becton, Dickinson And Company Cell culture substrates and methods of use
WO1995031473A1 (en) * 1994-05-11 1995-11-23 Organogenesis Inc. Collagen from cell cultures
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5618718A (en) 1994-12-30 1997-04-08 Universite Laval Production of a contractile smooth muscle
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5665391A (en) * 1995-10-12 1997-09-09 Spectral Diagnostics Inc. Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes
US5689961A (en) 1996-01-30 1997-11-25 Organogenesis Inc. Ice seeding apparatus for cryopreservation systems
US5766937A (en) 1996-02-15 1998-06-16 Becton Dickinson And Company Culture vessel and assembly
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
EP2295540A1 (de) * 1998-11-19 2011-03-16 Organogenesis, Inc. Biotechnisch konstruiertes Gewebe und Verfahren zu dessen Produktion und Benutzung
US6733530B1 (en) * 1999-08-02 2004-05-11 Eric Sun-Yin Chan Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin
CN100345452C (zh) * 2003-10-16 2007-10-24 华为技术有限公司 一种确定移动通信系统中用于加密同步的计数器检查发起时机的方法

Also Published As

Publication number Publication date
CN102051343A (zh) 2011-05-11
EP1131410A1 (de) 2001-09-12
AU2010201787A1 (en) 2010-05-27
AU769637B2 (en) 2004-01-29
EP1612265A2 (de) 2006-01-04
DE69927600T2 (de) 2006-07-06
JP5484975B2 (ja) 2014-05-07
CN1333818A (zh) 2002-01-30
WO2000029553A9 (en) 2000-11-09
CA2351396A1 (en) 2000-05-25
CA2351396C (en) 2012-08-14
HK1040740A1 (zh) 2002-06-21
WO2000029553A1 (en) 2000-05-25
DE69927600D1 (de) 2005-11-10
US20020172705A1 (en) 2002-11-21
JP2010187680A (ja) 2010-09-02
BR9915476A (pt) 2002-01-02
JP2002530069A (ja) 2002-09-17
US20080108134A1 (en) 2008-05-08
IL143243A0 (en) 2002-04-21
PT1612265E (pt) 2013-03-14
DK1131410T3 (da) 2005-10-31
EP1612265B1 (de) 2013-01-16
US7824913B2 (en) 2010-11-02
EP1131410B1 (de) 2005-10-05
ES2402739T3 (es) 2013-05-08
EP1612265A3 (de) 2006-03-01
AU2004201787A1 (en) 2004-05-27
ES2249928T3 (es) 2006-04-01
EP2295540A1 (de) 2011-03-16
AU2010201787B2 (en) 2012-09-13
AU1917100A (en) 2000-06-05

Similar Documents

Publication Publication Date Title
ATE305967T1 (de) Biotechnisch konstruiertes gewebe und verfahren zu dessen produktion und benutzung
WO2007092902A3 (en) Bioengineered tissue constructs and cardiac uses thereof
DE69417011D1 (de) Verfahren zur herstellung von kathoden komponenten und zu ihrer verwendung in elektrochemischen zellen
DE69925362D1 (de) Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
DE60336059D1 (de) Verfahren zu deren verwendung
DE122007000082I1 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
ATE234291T1 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
DE69726539D1 (de) Schaumglasgegenstand zur vorbereitung von oberflächen, verwendung dafür und verfahren zu dessen herstellung
ATE494010T1 (de) Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
DE50015883D1 (de) Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie
DE69304075D1 (de) Elektrochemischer zellenblock und verfahren zu seiner herstellung
DE69822183D1 (de) Stabile protein-nickelteilchen und methoden zu ihrer herstellung und verwendung
DE3860266D1 (de) Optisch aktive (meth)acrylamide, verfahren zu ihrer herstellung und ihre verwendung zur racematspaltung.
DE59003581D1 (de) Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung.
ES2172536T3 (es) Liberacion y movilizacion de celulas hematopoyeticas.
DE69812365D1 (de) Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung
WO2007103865A3 (en) Oral tissue regeneration and repair
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
DE69706690D1 (de) Acryloyl-substituierte distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel
DE69410181D1 (de) Alko- und oleophobe, fluorhaltige netzmittel und verfahren zu ihrer herstellung, sowie ihre verwendung
DE59010759D1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
ATE211482T1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
DE60132079D1 (de) Verfahren zur herstellung von bandersatzkonstruktionen
DE69711633D1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
DE50213507D1 (de) Verfahren und mittel zur beeinflussung von interzellulärer kommunikation und interzellulärem organellentransport

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131410

Country of ref document: EP